MRM (MEDIROM Healthcare Technologies) Long-Term Debt: $4.99 Mil (As of Jun. 2025)


MRM MEDIROM Healthcare Technologies Inc MRM
53 GF Score
Price $1.02
GF Value $4.07
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is MEDIROM Healthcare Technologies Long-Term Debt?

MEDIROM Healthcare Technologies MRM +3.39% 53 Long-Term Debt is $4.99 Mil as of Jun. 2025. GuruFocus rates MRM with a GF Score™ of 53/100 and a GF Value™ of $4.07 (Possible Value Trap). The stock has 8 warning signs investors should review.

MEDIROM Healthcare Technologies's Long-Term Debt for the quarter that ended in Jun. 2025 was $4.99 Mil.

MEDIROM Healthcare Technologies's quarterly Long-Term Debt declined from Jun. 2024 ($6.41 Mil) to Dec. 2024 ($4.97 Mil) but then increased from Dec. 2024 ($4.97 Mil) to Jun. 2025 ($4.99 Mil).

MEDIROM Healthcare Technologies's annual Long-Term Debt declined from Dec. 2022 ($8.52 Mil) to Dec. 2023 ($7.30 Mil) and declined from Dec. 2023 ($7.30 Mil) to Dec. 2024 ($4.97 Mil).

MEDIROM Healthcare Technologies  (NAS:MRM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

MEDIROM Healthcare Technologies Long-Term Debt Related Terms

MEDIROM Healthcare Technologies Long-Term Debt Historical Data

* Premium members only.

The historical data trend for MEDIROM Healthcare Technologies's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDIROM Healthcare Technologies Long-Term Debt Chart

MEDIROM Healthcare Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial 6.44 6.56 8.52 7.30 4.97

MEDIROM Healthcare Technologies Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.81 7.30 6.41 4.97 4.99
MRM
53GF Score
MEDIROM Healthcare Technologies Inc MRM
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $4.99 Mil mean?
MEDIROM Healthcare Technologies (MRM) has a Long-Term Debt of $4.99 Mil as of Jun. 2025.
Is MEDIROM Healthcare Technologies' Long-Term Debt too high?
MEDIROM Healthcare Technologies' current Long-Term Debt is $4.99 Mil. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' Long-Term Debt compare to EJH and CLIK?
MEDIROM Healthcare Technologies' Long-Term Debt of $4.99 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Personal Services company?
A good Long-Term Debt depends on the Personal Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. MEDIROM Healthcare Technologies's current Long-Term Debt is $4.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.07, compared to a current price of $1.02 — trading 74.9% below its estimated fair value. The current Long-Term Debt is $4.99 Mil. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current Long-Term Debt is $4.99 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?

Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued. The current stock price of $1.02 is trading 74.9% below its estimated GF Value™ of $4.07. GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.

Key valuation signals for MRM:

  • Long-Term Debt: $4.99 Mil
  • GF Value™: $4.07 vs. price of $1.02 (74.9% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MEDIROM Healthcare Technologies Business Description

Address 2-3-1 Daiba, 16th Floor, Tradepia Odaiba, Minato-ku, Tokyo, JPN, 135-0091
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score

Get the complete analysis for MRM

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.02
Price
$4.07
GF Value